Analysts have recently evaluated CytoSorbents and provided 12-month price targets. The average target is $7.75, accompanied ...

CytoSorbents Corporation (NASDAQ: CTSO ), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardiac surgery, today provided a regulatory update ...